When Anthropic announced its Claude Science initiative—a program to deploy its large language model against neglected tropical diseases—the crypto media cheered. Here was a flagship AI lab, a torchbearer of responsible development, turning its gaze to medicine. The narrative was seductive: democratize drug discovery, accelerate cures, bring the power of frontier models to researchers who lack Silicon Valley budgets.
But as I read the press release, a familiar unease settled in. Code is the new covenant, but trust is the ink. And where is the ink in this covenant? In Anthropic's servers, in its boardroom, in the whims of a centralized entity that can change its pricing, its safety filters, or its priorities with a single blog post. This is not democratization. It is the old feudal system dressed in algorithmic robes.
To understand why, we must look at the parallel universe growing quietly on blockchains: Decentralized Science, or DeSci. Platforms like VitaDAO, Molecule, and ResearchHub have been pioneering tokenized funding for early-stage research, creating liquid markets for intellectual property, and building transparent, on-chain governance for scientific collaboration. Their philosophy is radical: research should be owned by its contributors, not by a corporation's API key. They argue that the truest democratization of science requires not just access to a tool, but sovereignty over the data, the models, and the rewards. Anthropic's plan, for all its altruistic language, bypasses this entirely.
The Structural Limits of Centralized AI in Science
Let us dissect the announcement using the lens I learned in the trenches of DeFi and DAO governance. The core of Anthropic's offering is a model plus tool-calling capabilities. It is an application layer built on a black-box foundation. Based on my experience auditing early DAO proposals in 2017, I saw that when governance rights are undefined, the system eventually concentrates power. The same applies to scientific AI: if the model's reasoning cannot be inspected, if the training data is proprietary, if the safety filters are opaque, then the scientist using Claude is not a partner—she is a tenant.
Technical analysis reveals that Anthropic is not training a new molecular model. It is leveraging Claude 3.5's long-context and reasoning strengths to parse literature, generate hypotheses, and suggest molecules. That is powerful, but it is also fragile. The model's hallucination rates in scientific domains are not publicly benchmarked; we lack independent audits. In DeFi, we learned to expect audits as a baseline. In AI-driven drug discovery, an undetected hallucination could send a team down a blind alley for years.
Moreover, the data pipeline is centralized. Anthropic will decide which databases to integrate, which papers to index, which safety filters to apply. This creates a single point of failure for censorship, for bias, for commercial capture. Imagine a future where Claude refuses to suggest a molecule that might compete with a pharmaceutical partner of Anthropic. That is not a conspiracy theory; it is the logical outcome of a system where access is granted by a corporate entity. Ownership is not a receipt; it is a soul. And this program offers the receipt of inference, not the soul of collective stewardship.
The Commercial Reality: PR Over Profit
The analysis of the business model confirms what many of us suspected: this is high-PR, low-revenue. Neglected diseases are not a lucrative market. The true payoff is brand elevation, talent acquisition, and a data moat that can later be turned into a paid product for Big Pharma. This is a classic platform play. But blockchain-based DeSci offers an alternative: tokenized research funding that aligns incentives from day one. Projects like AthenaDAO raise capital from a community of contributors who vote on which research to fund, and the IP is tokenized and traded. The scientist retains control; the community shares the upside. No central gatekeeper.
During the 2020 DeFi Summer, I worked on a lending protocol that insisted on embedding user education layers. We launched late, but our error rate dropped 40%. That lesson stuck: technology must serve human dignity, not just capital efficiency. Anthropic’s Claude Science serves efficiency. It helps researchers do more with less. But it does not change the underlying power asymmetry. The researcher remains dependent on Anthropic’s continued goodwill, pricing, and compliance. In the chaotic cycles of crypto, we have seen too many centralized protocols change rules overnight. The safeguard is code that cannot be overridden, not a promise.
The Illusion of Democratization
The term “democratization” is overused. Real democratization requires that the user can verify, fork, and exit without losing value. Anthropic offers none of that. The model is closed-source. The training data is secret. The fine-tuning procedure is undocumented. A scientist who builds a workflow around Claude today may find that workflow broken tomorrow by an API update. There is no recourse, no governance vote, no community treasury to support a transition. This is the very definition of vendor lock-in.
In contrast, the DeSci ecosystem is experimenting with on-chain model registries, where scientific AI models are published with verifiable training logs and inference proofs. Projects like Ocean Protocol allow data to be shared without surrendering ownership. The Bittensor network enables a decentralized marketplace for AI inference, where multiple models compete and the best ones are rewarded in tokens. These are not theoretical. They are live, albeit nascent. The contrarian view is that DeSci is too slow, too fragmented, and too reliant on token volatility. That is fair. But speed is not the only virtue. Resilience is. A decentralized network can survive the bankruptcy of its founders. Anthropic cannot.
And let us not ignore the dual-use risk. Anthropic, an organization known for its safety research, may have implemented filters to prevent misuse. But those filters are opaque. In a decentralized system, the community can propose and vote on safety parameters, and the code enforces them. There is no benevolent dictator. There is only consensus. In the chaos of consensus, I seek the quiet truth: that human dignity is better protected when no single entity holds the keys to knowledge.
The Hybrid Future
I am not suggesting that Claude Science is worthless. On the contrary, it is a validation that AI can accelerate science. But it is a half-step. The real revolution will come when these AI capabilities are wrapped in decentralized governance, transparent data pipelines, and verifiable computation. Perhaps that is the next phase: Anthropic could open-source a version of its scientific model, or deploy it on a blockchain to prove inference integrity. Or maybe a new project will emerge, combining the best of both worlds: a foundation model trained on community-owned data, governed by token holders, and auditable by anyone.
During my 2026 project building a decentralized verification layer for AI content, I saw that trust is not given; it is engineered, then earned. Anthropic has engineered a powerful tool. It has not earned the trust that comes with verifiable, decentralized ownership. That trust must be built with code that is open, governance that is inclusive, and incentives that are aligned. Until then, Claude Science will be a beautiful experiment, but not a true democratization.
Trust is not given; it is engineered, then earned. The question remains: will Anthropic engineer the transparency to earn it?